AKT1 and leukemia: This idea issupported by studies in other cancer types, including leukemia, head and necksquamous cell carcinoma, and non-small cell lung cancer, where cytotoxicity isenhanced, in some cases synergistically, when HDAC and Akt inhibition arecombined [42–44].